Ascyrus Medical Dissection Stent Hybrid Prosthesis - Aortic arch endovascular stent-graft - ARTG 409514
Access comprehensive regulatory information for Ascyrus Medical Dissection Stent Hybrid Prosthesis - Aortic arch endovascular stent-graft in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 409514 and sponsored by Cryolife Medical (Australia) Company Pty Ltd, manufactured by Ascyrus Medical GmbH in Germany. The device registration started on May 24, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The AMDS is intended for aortic repair, aortic remodeling and re-expansion of the intimal flap within the ascending aorta, aortic arch, and into the descending aorta for patients with acute DeBakey Type I aortic dissections undergoing open surgical repair within 0-14 days of diagnosis.